74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Bruker Corp
Closed
SectorHealthcare
38.92 2.69
Overview
Share price change
24h
Min
36.92
Max
38.93
Income | -27M 14M |
|---|---|
Sales | 115M 980M |
P/E Sector Avg | 47.342 57.333 |
EPS | 0.76 |
Dividend yield | 0.56 |
Profit margin | 1.419 |
Employees | 11,396 |
EBITDA | -60M 72M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +60.99% upside |
Dividend yield Sector Avg | 0.56% 2.63% |
|---|---|
Next Earnings | 7 May 2025 |
Next Dividend date | 16 Jun 2025 |
Next Ex Dividend date | 30 May 2025 |
Market Cap | -3.3B 5.5B |
|---|---|
Previous open | 36.23 |
Previous close | 38.92 |
Technical Score
By Trading Central
Confidence
Neutral Evidence
Bruker Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Bruker Corp Forecast
Price Target
By TipRanks
60.99% upside
12 Months Forecast
Average 61 USD 60.99%
High 80 USD
Low 45 USD
Based on 9 Wall Street analysts offering 12 month price targets forBruker Corp - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Bruker Corp
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
